The Gynecologic Oncology Group
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1970-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.gog.org
Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer
- Conditions
- Precancerous ConditionStage 0 Cervical Cancer
- Interventions
- Other: Cervical Papanicolaou TestProcedure: ConizationOther: Laboratory Biomarker Analysis
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-05-29
- Lead Sponsor
- Gynecologic Oncology Group
- Target Recruit Count
- 684
- Registration Number
- NCT00003384
- Locations
- 🇺🇸
Gynecologic Oncology Group of Arizona, Phoenix, Arizona, United States
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
- Conditions
- Endometrial Clear Cell AdenocarcinomaStage III Uterine Corpus CancerEndometrial Serous AdenocarcinomaStage IV Uterine Corpus Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2014-12-31
- Lead Sponsor
- Gynecologic Oncology Group
- Target Recruit Count
- 35
- Registration Number
- NCT00005840
- Locations
- 🇺🇸
Gynecologic Oncology Group, Philadelphia, Pennsylvania, United States
Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy
- Conditions
- Ovarian CancerPrimary Peritoneal Cavity Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-05-27
- Lead Sponsor
- Gynecologic Oncology Group
- Registration Number
- NCT00006028
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, United States
🇺🇸University of Chicago Cancer Research Center, Chicago, Illinois, United States
Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
- Conditions
- Cervical Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-05-27
- Lead Sponsor
- Gynecologic Oncology Group
- Registration Number
- NCT00016926
- Locations
- 🇺🇸
Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States
🇺🇸Chao Family Comprehensive Cancer Center, Orange, California, United States
🇺🇸Holden Comprehensive Cancer Center, Iowa City, Iowa, United States
Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer
- Conditions
- Cervical Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-05-27
- Lead Sponsor
- Gynecologic Oncology Group
- Target Recruit Count
- 40
- Registration Number
- NCT00003379
- Locations
- 🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
🇺🇸MBCCOP - University of Illinois at Chicago, Chicago, Illinois, United States
🇺🇸Ireland Cancer Center, Cleveland, Ohio, United States
Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer
- Conditions
- Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-05-27
- Lead Sponsor
- Gynecologic Oncology Group
- Target Recruit Count
- 48
- Registration Number
- NCT00003385
- Locations
- 🇺🇸
MBCCOP - Hawaii, Honolulu, Hawaii, United States
🇺🇸Ireland Cancer Center, Cleveland, Ohio, United States
🇺🇸Holden Comprehensive Cancer Center, Iowa City, Iowa, United States
Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
- Conditions
- Cervical Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-05-27
- Lead Sponsor
- Gynecologic Oncology Group
- Target Recruit Count
- 400
- Registration Number
- NCT00003945
- Locations
- 🇺🇸
Mercy Cancer Center at Mercy Medical Center-Des Moines, Des Moines, Iowa, United States
🇺🇸John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines, Iowa, United States
🇺🇸Indiana University Cancer Center, Indianapolis, Indiana, United States
Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus
- Conditions
- Sarcoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-04-11
- Lead Sponsor
- Gynecologic Oncology Group
- Registration Number
- NCT00033644
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, United States
🇺🇸Tuft-New England Medical Center, Boston, Massachusetts, United States
Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix
- Conditions
- Cervical Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-04-11
- Lead Sponsor
- Gynecologic Oncology Group
- Registration Number
- NCT00030472
- Locations
- 🇺🇸
Community Hospital of Los Gatos, Los Gatos, California, United States
🇺🇸Tufts - New England Medical Center, Boston, Massachusetts, United States
🇺🇸State University of New York Health Sciences Center - Stony Brook, Stony Brook, New York, United States
Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
- Conditions
- Endometrial Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-04-11
- Lead Sponsor
- Gynecologic Oncology Group
- Target Recruit Count
- 2108
- Registration Number
- NCT00002976
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
🇺🇸Veterans Affairs Medical Center - West Los Angeles, Los Angeles, California, United States